Searched for
PROSTATE CANCER DRUG
Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...
- US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claimsA US judge has dismissed Bayer's plea to halt Johnson & Johnson's advertising for its prostate cancer drug Erleada. Bayer alleged false cla...
- AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drugAstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) 100mg and...
- Zydus launches pill for prostate cancer patientsThe drug firm said the medication would cost Rs 6,995 per month, which is 50 per cent less than the currently available injectable options....
- 'Can treat tumors that you cannot see'. Radiation drugs hunt & kill cancer cells, says new studyThe drug in this case is a molecule that contains two parts: a tracker and a cancer-killing payload.
- IIT researchers find new molecule that can be used as targeted therapy to treat prostate cancerThe molecule has shown potency in cells to completely reduce tumour in 50 days.
- BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in IndiaThe company had earlier received approval from the Drugs Controller General of India (DCGI) to manufacture 40 mg enzalutamide in 2017 to tr...
- Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these ...
- New 3-in-1 blood test can transform the treatment of advanced prostate cancerThe test could help to extend or save lives, by targeting treatment more effectively.
- 'Repurposing' malaria drug to treat castrate-resistant prostate cancerKolkata, March 26 (IANS) Tapping into the trend of repurposing old approved drugs to treat totally different diseases -- a strategy that le...
- Panacea launches prostate cancer drugDrug firm Panacea Biotec today launched Cabapan injection, an indigenously developed drug for treating prostate cancer.
Load More
